TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ABBV

AbbVie Inc

Healthcare · Drug Manufacturers - General

262.80$ +1.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABBV
Line item 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 38.9% 37.7% 56.8% 61.1% 58.4% 30.8% 24.5% 30.0% 28.6% 55.6% 16.1% 19.1% 20.5% 24.5% 18.9% 21.7%
– 0.0% 0.1% 21.8% 32.9% 30.3% 15.8% 7.7% 13.1% 12.3% 44.8% 5.6% 6.7% 6.6% 9.5% 4.1% 3.9%
– 0.1% 3.3% 29.5% 33.9% 30.4% 15.8% 9.7% 13.8% 13.6% 44.8% 5.6% 6.7% 6.6% 9.5% 4.1% 3.9%
– 16.0% 19.6% 15.9% 16.4% 13.6% 8.9% 7.2% 7.2% 9.1% 6.1% 5.9% 6.8% 8.1% 8.3% 8.1% 9.4%
– 4.0% 4.5% 4.0% 3.9% 4.1% 3.2% 2.2% 2.3% 2.7% 2.0% 2.2% 2.1% 2.6% 3.0% 3.1% 3.7%
– 11.2% 11.0% 8.3% 7.9% 9.0% 4.8% 3.9% 4.0% 4.9% 3.3% 3.5% 3.5% 3.6% – – –
– 29.3% 31.2% 22.7% 21.5% 21.3% 24.8% 23.3% 22.3% 26.4% 17.5% 22.0% 22.1% 23.2% 24.0% 25.9% 26.6%
– 17.5% 14.9% 8.6% 6.5% 5.5% 37.2% 43.7% 38.9% 35.8% 20.9% 55.0% 51.8% 48.6% 41.3% 44.4% 39.3%
– 25.7% 38.9% 87.5% 84.6% 93.7% 92.6% 93.0% 92.8% 114.2% 109.2% 91.3% 89.5% 87.5% 92.3% 97.5% 102.4%
– 17.8% 30.2% 25.1% 23.6% 41.4% 20.5% 14.8% 23.5% 29.0% 17.5% 19.0% 24.0% 21.3% 28.1% 28.7% 32.3%
– – 0.1% 3.9% 1.5% 16.1% 4.6% 0.6% 9.1% 8.9% 4.2% 5.8% 8.6% 3.1% 5.3% 5.0% 6.5%
– 1.7% 2.1% 2.1% 3.2% 5.1% 3.0% 2.1% 2.1% 2.6% 1.6% 1.5% 2.0% 2.1% 2.7% 2.2% 2.7%
– – 0.2% 54.2% 48.9% 38.4% 55.1% 55.1% 43.7% 59.0% 70.7% 51.5% 43.8% 42.6% 38.7% 44.6% 44.0%
– 74.3% 61.1% 12.5% 15.4% 6.3% 7.4% 7.0% 7.2% -14.2% -9.2% 8.7% 10.5% 12.5% 7.7% 2.5% -2.4%
– – – – 5.4% 1.9% 4.2% 6.6% 7.7% 5.7% 5.3% 0.7% 2.1% 3.4% -0.7% -5.8% -11.6%
– 7.7% 8.3% 5.8% 5.5% 5.9% 3.1% 2.5% 2.3% 2.6% 1.7% 1.1% 1.2% 1.3% 1.3% 1.3% 1.3%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?